Last's week Presentation:
The presentation is available to public on the link in the previous post, you may have to still sign up. It is also available on co.web site. It is tricky to get both audio and the 22 page power point as it depends which OS you are using and which version of chrome or IE etc. I use Windows 7 and used IE and had to use the Flash player selection at the bottom, windows media player did not work.
It is worth the effort if you are interested in this stock. 20 min Presentation by CEO with a little Q and A at the end. The PP presentation is 22 pages and very informative. The most notable things to me were he again mentioned ongoing efforts to uplist. Also, in the ongoing trial studies, if any of them are successful, most would generate tens of $million per year in revenue but if the Rhu Arthritis vaccine is successful, it would potentially generate 100's of $millions per year in revenue. Also, Big Pharma will know prior to releasing the final results and approvals by various FDA's worldwide their chances and if things are looking good would probably want to lock up a supply contract in advance since all big pharma know that the KLH supply is quite limited and it is just a matter of time before Natural Harvesting will be banned to protect the already rare species. If 3 or 4 trials are successful, probably would be a supply shortage, at least at first. Also, he said burn rate is about $500k a month and they can run through 2015 with current cash on hand with no new revenue.
AI
